Company intelligence / Profile preview

Articulinx

Cupertino, California, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

Articulinx developed the "Articulinx CMC Spacer," an implantable device designed to treat hand osteoarthritis by acting as a spacer between bones where articular cartilage has degenerated. The device can be implanted through a small incision under local anesthesia. No clinical results or commercial launch data are available in public sources.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

US Venture Partners (investor)De Novo Ventures (investor)

Beyond the preview

Go deeper on Articulinx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Articulinx.

Explore the full profile